Propantheline Bromide
溴丙胺太林
Report date: 2023/02/08 16:34:14
NME
Base Information
Drug NamePropantheline Bromide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved Indications +[9]
Approved Indications in China +[8]
Original Approved Country/Territory
Original Approved Date1953/04/02
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer IncHubei Pharmaceutical Co Ltd
Inactive CompaniesShire Development Llc
Active Indications +[8]
Inactive Indications